test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MMSIMerit Med Sys Inc
Recent Activity
New Position
2.48%
$8.401M
85,000 shares@ $98.83 avg price
RZLTRezolute Inc
Recent Activity
2.43%
$8.245M
1.7M shares@ $4.85 avg price
PCVXVaxcyte Inc
Recent Activity
New Position
2.43%
$8.227M
72,000 shares@ $114.27 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
2.36%
$8M
610,000 shares@ $13.12 avg price
VKTXViking Therapeutics Inc
Recent Activity
Increased 3.28%
2.35%
$7.977M
126,000 shares@ $63.31 avg price
CPRXCatalyst Pharmaceuticals Inc
Recent Activity
Decreased -23%
2.26%
$7.654M
385,000 shares@ $19.88 avg price
CTNMContineum Therapeutics Inc
Recent Activity
Decreased -14.02%
2.08%
$7.065M
369,126 shares@ $19.15 avg price
ARWRArrowhead Pharmaceuticals In
Recent Activity
New Position
2.03%
$6.876M
355,000 shares@ $19.37 avg price
SVRASavara Inc
Recent Activity
Decreased -1.25%
1.97%
$6.678M
1.575M shares@ $4.24 avg price
IRTCIrhythm Technologies Inc
Recent Activity
New Position
1.88%
$6.385M
86,000 shares@ $74.24 avg price